REQUEST A DEMO
Total
USD $0.00
Search more companies

JEIL Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: JEIL Pharmaceutical Co., Ltd. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

JEIL Pharmaceutical Co., Ltd. is engaged in developing and supplied superior pharmaceutical products. The company has two new drug development research laboratories such as synthesis research laboratory and formulation research laboratory which are actively engaged in conducting research into complete manufacture and ingredients of innovative new drugs, incrementally modified drugs, and generic drugs. JEIL Pharmaceutical Co., Ltd also produces solid medicines and injections, finished pharmaceutical products including patches, and Active Pharmaceutical Ingredients(APIs) such as anti-biotic ingredients, among others. In addition, the company exports synthetic ingredients such as Cefditoren Pivoxil, Epinastine HCl, etc. to different locations including Japan and China, while also exporting finished products like Kefentech Plaster (Ketoprofen), Cilapenem Injection (Imipenem / Cilastatin Sodium), etc. to around 30 countries in ASEAN, Central and South America, Africa, etc. JEIL Pharmaceutical Co., Ltd is incorporated in 2017 and is based in Seoul South Korea.

Headquarters
343, Sapyeong-Daero, Seocho-Gu
Seoul; Seoul;

Contact Details: Purchase the JEIL Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.jeilpharm.co.kr

Basic Information
Total Employees:
Purchase the JEIL Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the JEIL Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the JEIL Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the JEIL Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
June 01, 2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
48.7%
Purchase this report to view the information.
6.9%
Purchase this report to view the information.
3%
Subsidiaries
Jeil Pharma Holdings Inc.
Company Performance
Financial values in the chart are available after JEIL Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.74%
Total operating revenue
-0.56%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
15.54%
Total equity
5.22%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
16.69%
Quick Ratio
-0.04%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?